SCHEMBL3668334

SCHEMBL3668334

CC(C)(C)[Si](C)(C)Oc1ccc(C(=O)c2ccccc2)cc1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.52
CYP2C19 P33261 2/20 0.52
CYP2D6 P10635 1/20 0.52
HPGD P15428 1/20 0.52
ELANE P08246 12/20 0.48
PTGS1 P23219 1/20 0.45
PTGS2 P35354 1/20 0.45
ATM Q13315 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
ABCC9 O60706 1/20 0.43
ABCC8 Q09428 1/20 0.43
KCNJ11 Q14654 1/20 0.43
KCNJ8 Q15842 1/20 0.43
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8940576 0.84 CA12 (0.51) HPGDTSHRALDH1A1GAA
SCHEMBL1070595 0.82 KMT2A (0.39) CYP1A2CYP2C19CYP2D6HPGDELANE
SCHEMBL5280416 0.81 ELANE (0.57) ELANEALDH1A1GAA
SCHEMBL30785086 0.81 STS (0.50) CYP1A2CYP2C19CYP2D6HPGDELANE
SCHEMBL9688347 0.80 DRD2 (0.40) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL6456490 0.79 TUBB4A (0.59) CYP1A2CYP2C19CYP3A4CYP2C9TSHR
SCHEMBL6804381 0.79 MAPT (0.50) HPGDATMTDP1ALDH1A1GAA
SCHEMBL4823248 0.78 ALDH1A1 (0.55) CYP1A2CYP2C19L3MBTL1CYP3A4CYP2C9
SCHEMBL4819801 0.78 ALDH1A1 (0.55) CYP1A2CYP2C19L3MBTL1CYP3A4CYP2C9
SCHEMBL1975152 0.78 CA12 (0.65) CYP1A2CYP2C19CYP3A4CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11117987-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2021-09-14 US disclosed
US-11028195-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2021-06-08 US disclosed
US-20190322777-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2019-10-24 US disclosed
US-20190233557-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2019-08-01 US disclosed
US-10227425-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2019-03-12 US disclosed
EP-2937365-B1 METHOD OF MAKING HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORP (JP) 2016-12-14 EP disclosed
EP-2589611-B1 Method for making hydroxyaryl functionalized polymers BRIDGESTONE CORP (JP) 2016-10-26 EP disclosed
EP-2937365-A1 METHOD OF MAKING HYDROXYARYL FUNCTIONALIZED POLYMERS Bridgestone Corporation (JP) 2015-10-28 EP disclosed
EP-2231719-B1 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORP (JP) 2015-07-29 EP disclosed
US-20150141582-A1 Hydroxyaryl Functionalized Polymers BRIDGESTONE CORPORATION (JP) 2015-05-21 US disclosed
US-8871871-B2 Hydroxyaryl functionalized polymers BRIDGESTONE CORPORATION (JP) 2014-10-28 US disclosed
EP-2589611-A1 Hydroxyaryl functionalized polymers Bridgestone Corporation (JP) 2013-05-08 EP disclosed
US-20100286348-A1 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORPORATION (JP) 2010-11-11 US disclosed
EP-2231719-A2 HYDROXYARYL FUNCTIONALIZED POLYMERS Bridgestone Corporation (JP) 2010-09-29 EP disclosed
WO-2009086490-A2 HYDROXYARYL FUNCTIONALIZED POLYMERS BRIDGESTONE CORPORATION (JP) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190322777-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL CYP1A2 103/4885CYP2C19 163/4885CYP2D6 633/4885
US-11028195-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL CYP1A2 125/4885CYP2C19 202/4885CYP2D6 766/4885
US-10227425-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL CYP1A2 103/4885CYP2C19 163/4885CYP2D6 633/4885
US-20150141582-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL CYP1A2 103/4885CYP2C19 163/4885CYP2D6 633/4885
US-20100286348-A1 HYDROXYARYL FUNCTIONALIZED POLYMERS HAAO, HCAR3, VCL CYP1A2 103/4885CYP2C19 163/4885CYP2D6 633/4885
US-11117987-B2 Hydroxyaryl functionalized polymers HAAO, HCAR3, VCL CYP1A2 103/4885CYP2C19 163/4885CYP2D6 633/4885
US-20190233557-A1 Hydroxyaryl Functionalized Polymers HAAO, HCAR3, VCL CYP1A2 125/4885CYP2C19 202/4885CYP2D6 766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.